CALD1 and neoplasm: A loss of expression of caldesmon is associated with enhanced cellular motility due to cytoskeletal rearrangements; however, caldesmon appears to have a dual role in tumor progression, as epithelial‐to‐mesenchymal transformation results in higher expression of caldesmon in vitro 33, 34.